Yahoo Finance Today's Research Reports on Trending Tickers: Exact Sciences and NovoCure
NEW YORK, NY / ACCESSWIRE / August 24, 2018 / U.S. markets plunged on Thursday following the release of the minutes from the latest Federal Reserve meeting, which called for an interest hike in September. Investors appear to be focused on the upcoming speech from Federal Reserve Chairman Jerome Powell's this Friday. The Dow Jones Industrial Average dropped 0.30 percent to close at 25,656.98, while the S&P 500 Index declined 0.17 percent to close at 2,856.98, as 10 out of 11 sectors ended in the red. The Nasdaq Composite Index shed 0.13 percent to close at 7,878.46.
“Look, it’s late August, things are moving around,” according to Sahak Manuelian, managing director of equity trading at Wedbush Securities. “I’m not being dismissive of these moves lower but I think it’s important to put it into context, and take a step back,” he added.
RDI Initiates Coverage on:
Exact Sciences Corporation
https://rdinvesting.com/news/?ticker=EXAS
NovoCure Limited
https://rdinvesting.com/news/?ticker=NVCR
Exact Sciences' stock jumped 4.07% Thursday, to close the day at $67.98. The stock recorded a trading volume of 12,580,287 shares, which was above its three months average volume of 2,430,825 shares. In the last year, Exact Sciences' shares have traded in a range of 37.36 - 73.72. The share price has gained 81.96% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $57.83 is above its 200-day moving average of $53.12. Shares of Exact Sciences have gained roughly 3.06 percent in the past month and are up 29.39 percent year-to-date.
Access RDI's Exact Sciences Corporation Research Report at:
https://rdinvesting.com/news/?ticker=EXAS
On Thursday, shares of NovoCure recorded a trading volume of 746,041 shares, which was above the three months average volume of 710,520 shares. The stock ended the day 4.23% higher at $39.40. The share price has fallen 0.76% from its 52 week high with a 52 week trading range of 16.10 - 39.70. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $35.36 is above its 200-day moving average of $28.04. Shares of NovoCure have gained roughly 2.87 percent in the past month and are up 95.05 percent year-to-date.
Access RDI's NovoCure Limited Research Report at:
https://rdinvesting.com/news/?ticker=NVCR
Our Actionable Research on Exact Sciences Corporation (NASDAQ:EXAS) and NovoCure Limited (NASDAQ:NVCR) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
